Healthcare Services

Cryptococcosis market forecast with demand insights

April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Cryptococcosis Market During 2026–2030?

The cryptococcosis market has experienced significant expansion in recent years. Its value is projected to rise from $7.07 billion in 2025 to $7.71 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.9%. The growth observed in the historical period can be attributed to high hiv aids prevalence, increasing organ transplant procedures, limited early diagnostic capabilities, reliance on amphotericin b therapy, and hospital-centered infection management.

The cryptococcosis market is projected to experience substantial expansion over the coming years, reaching $10.8 billion by 2030, driven by a compound annual growth rate (CAGR) of 8.8%. This projected increase is linked to several factors including enhancements in fungal diagnostics, a growing population of immunocompromised individuals, heightened awareness of cryptococcal meningitis, the creation of more secure antifungal treatments, and better availability of healthcare services. Key trends anticipated during this period encompass a greater emphasis on detecting fungal infections early, an uptick in the adoption of combination antifungal therapies, more intensive monitoring of patients with weakened immune systems, the broadening of hospital-provided fungal care, and enhanced access to molecular diagnostic techniques.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cryptococcosis-global-market-report

What Factors Are Contributing To The Growth Of The Cryptococcosis Market?

The increasing prevalence of human immunodeficiency virus (HIV) is anticipated to stimulate the growth of the cryptococcosis market. HIV is a virus that compromises the immune system by specifically targeting CD4 cells, leaving the body vulnerable to various infections and diseases. The rise in HIV prevalence is linked to inadequate public awareness and education concerning its transmission and prevention, which fosters risky behaviors, delayed diagnoses, and an accelerated unintentional spread of the virus. As HIV weakens the immune system, individuals become more susceptible to opportunistic infections such as cryptococcosis. A higher number of HIV cases consequently increases the risk of cryptococcal infections, thereby driving demand for effective treatments and promoting market expansion. For example, in October 2024, the UK Health Security Agency, a UK-based government agency, indicated that human immunodeficiency virus (HIV) diagnoses totaled 6,008 in 2023, representing a 51% increase from the 3,975 recorded in 2022. Thus, the increasing prevalence of human immunodeficiency virus (HIV) is propelling the growth of the cryptococcosis market.

How Is The Cryptococcosis Market Segmented Across Different Segment Categories?

The cryptococcosis market covered in this report is segmented –

1) By Treatment Type: Adjunctive Therapies, Antifungal Drugs

2) By Diagnostic Technique: Culture Methods, Microscopic Examination, Molecular Methods

3) By Infection Type: Cerebral Cryptococcosis, Pulmonary Cryptococcosis

4) By End User: Clinics, Home Healthcare, Hospitals, Research Institutes

Subsegments:

1) By Adjunctive Therapies: Immunotherapy, Surgery, Supportive Care

2) By Antifungal Drugs: Amphotericin B, Fluconazole, Itraconazole, Voriconazole

What Trends Are Shaping The Future Of The Cryptococcosis Market?

Leading companies in the cryptococcosis market are heavily involved in clinical trials, aiming to develop antifungal treatments that are both safer and more effective. Clinical trials play a vital role in assessing new therapies and improving patient outcomes for those afflicted with severe fungal infections. For example, in August 2023, Matinas BioPharma Holdings Inc., a US-based clinical-stage biopharmaceutical company, disclosed positive results from its Phase II EnACT trial, which was evaluating MAT2203 for treating cryptococcal meningitis. MAT2203 is an oral lipid nanocrystal formulation of amphotericin B that works by targeting fungal cell membranes, thereby disrupting their structure and leading to fungal cell death. The study showed enhanced patient survival rates and a favorable safety profile, highlighting its potential as a breakthrough treatment for cryptococcosis, including cryptococcal meningitis.

Which Organizations Play A Role In The Cryptococcosis Market Landscape?

Major companies operating in the cryptococcosis market are Pfizer Inc, Johnson & Johnson, Merck and Co Inc, Abbott Laboratories, Gilead Sciences Inc, Asahi Kasei Pharma Corporation, Viatris Inc, Astellas Pharma Inc, Bausch Health Companies Inc, Sun Pharmaceutical Industries Ltd, Cipla Limited, Dr Reddys Laboratories, Century Pharmaceuticals Ltd, Beijing Lunarsun Pharmaceutical Co Ltd, Matinas Biopharma Holdings Inc, LGM Pharma, Atom Pharma, Brundavan Laboratories Pvt Ltd, Amar Healthcare, Novartis AG, Sanofi SA, Bristol Myers Squibb, Teva Pharmaceutical Industries Ltd, Lupin Limited, Glenmark Pharmaceuticals Ltd

Get The Full Cryptococcosis Market Report:

https://www.thebusinessresearchcompany.com/report/cryptococcosis-global-market-report

Which Region Accounts For The Largest Portion Of The Cryptococcosis Market?

North America was the largest region in the cryptococcosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cryptococcosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cryptococcosis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cryptococcosis-global-market-report

Browse Through More Reports Similar to the Global Cryptococcosis Market 2026, By The Business Research Company

Nontuberculous Mycobacterial Infection Market Report 2026

https://www.thebusinessresearchcompany.com/report/nontuberculous-mycobacterial-infection-global-market-report

Crypto Wallet Market Report 2026

https://www.thebusinessresearchcompany.com/report/crypto-wallet-global-market-report

Cephalosporin Market Report 2026

https://www.thebusinessresearchcompany.com/report/cephalosporin-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795